Copertina

Large‐Scale Analysis of Age and Sex Effects on Corrected QT and JT Intervals: Insights From Hospital‐Based Controls and Moxifloxacin‐Treated Cases

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Eunwoo Kim, Hyun Young Lee, Young‐Min Ye, Anhye Kim
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical and Translational Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
di: Wonsuk Shin, et al.
Pubblicazione: (2024)

Concentration–Response Analysis of the Combination of Pyronaridine and Piperaquine on Corrected QT Interval From a Randomized, Double‐Blind, Placebo‐Controlled Study in Healthy Adults of African Sub‐Saharan Origin
di: Mathieu Felices, et al.
Pubblicazione: (2025)

Assessment of QT Interval Prolongation Using Concentration– QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals
di: Noemi Kaetterer, et al.
Pubblicazione: (2025)

Surfing the T Wave: A Primer on ECG T Wave Morphologies Encountered in Clinical Trials and Impact on the QT Interval and Patient Safety
di: Robert M. Lester, et al.
Pubblicazione: (2025)

Exploration of Using an Open‐Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements
di: Ki Young Huh, et al.
Pubblicazione: (2025)

CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab
di: Yerim Kim, et al.
Pubblicazione: (2025)

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males
di: Heejae Won, et al.
Pubblicazione: (2024)

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
di: Sungyeun Bae, et al.
Pubblicazione: (2026)

CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
di: Ji Hye Shin, et al.
Pubblicazione: (2024)

Mini bat organs reveal hidden viral threats
di: Hyunjoon Kim, et al.
Pubblicazione: (2025)

Integrating Personal Health Records to Improve Data Integrity in Trials With Decentralized Elements: A Pilot Study
di: Yoonjin Kim, et al.
Pubblicazione: (2025)

Proteomic profiling of the serum of patients with COVID‐19 reveals key factors in the path to clinical improvement
di: Hye Seong, et al.
Pubblicazione: (2025)

Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria
di: Kun‐Woo Park, et al.
Pubblicazione: (2026)

NMDAR‐Antibody Encephalitis Diagnosed With Primary Central Nervous System Lymphoma: A Case Series
di: Soo Hyun Ahn, et al.
Pubblicazione: (2025)

Pharmacokinetic comparison of subcutaneously administered CT‐P13 (biosimilar of infliximab) via autoinjector and pre‐filled syringe in healthy participants
di: Ye Chan Park, et al.
Pubblicazione: (2024)

Spatial distribution of immune cells and their proximity to STING+ cells are associated with survival in glioblastoma
di: Hanwool Jeon, et al.
Pubblicazione: (2025)

Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2 infection and vaccination
di: Hyunkyung Cha, et al.
Pubblicazione: (2026)

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing
di: Mirja Thomsen, et al.
Pubblicazione: (2025)

Real‐World Effectiveness of Rebamipide on Gastritis Symptoms: A Patient‐Focused Approach
di: Hyun Ji Woo, et al.
Pubblicazione: (2025)

Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients
di: Victor Poon, et al.
Pubblicazione: (2025)

Revealing Non‐Motor Symptom Profiles of Orthostatic Hypotension Subtypes in Parkinson's Disease: Insights From a Multidimensional Case–Control Study
di: Zihan Wang, et al.
Pubblicazione: (2026)

Evaluation of the Effect of Loperamide on the Cardiac Repolarization Interval Using Exposure–Response Analysis
di: Belén Valenzuela, et al.
Pubblicazione: (2025)

Cross‐Reactive NSAID Hypersensitivity: Clinical Findings From Aspirin Provocation and Alternative Drug Challenge Testing
di: Young‐Il Koh, et al.
Pubblicazione: (2025)

Clinical characteristics and risk factors for escalation to anaphylaxis from non‐severe drug hypersensitivity reaction
di: Hyo‐In Rhyou, et al.
Pubblicazione: (2025)

Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
di: Young‐Sim Choi, et al.
Pubblicazione: (2025)

Model‐Informed Optimal Dosing of Anti‐CD47 Antibody Using Target‐Mediated Drug Disposition Model
di: Seongmee Jeong, et al.
Pubblicazione: (2025)

Interleukin‐2/anti‐interleukin‐2 immune complex attenuates cold ischemia‐reperfusion injury after kidney transplantation by increasing renal regulatory T cells
di: Joon Young Jang, et al.
Pubblicazione: (2024)

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease
di: Minji Lee, et al.
Pubblicazione: (2024)

Genomic classification of intrapulmonary metastasis and multiple primary lung cancer
di: Jeongsoo Won, et al.
Pubblicazione: (2025)

A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants
di: Shichang Miao, et al.
Pubblicazione: (2024)

Bidirectional crosstalk between cancer cells and cancer‐associated fibroblasts in mixed organoid system elicits transcriptomic characteristics of pancreatic cancer with potential therapeutic vulnerabilities
di: Jae‐Il Choi, et al.
Pubblicazione: (2024)

Ubiquitin: Not just a one‐way ticket to the proteasome, but a therapeutic dial to fine‐tune the molecular landscape of disease
di: A. Hyun Kim, et al.
Pubblicazione: (2024)

Antibody responses as correlates of protection against SARS‐CoV‐2 in the Omicron era: A 5‐month prospective cohort study in Korean healthcare workers’
di: So Yun Lim, et al.
Pubblicazione: (2024)

Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies
di: Jun Morita, et al.
Pubblicazione: (2026)

Correction to “Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety”
Pubblicazione: (2025)

Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated With Sertraline
di: Samuel Gerlach, et al.
Pubblicazione: (2026)

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study
di: Byung Hak Jin, et al.
Pubblicazione: (2024)

Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea
di: Ki Young Huh, et al.
Pubblicazione: (2024)

ALS With and Without Upper Motor Neuron Signs: A Comparative Study Supporting the Gold Coast Criteria
di: Hee‐Jae Jung, et al.
Pubblicazione: (2025)

Insights From a User Experience‐Focused Virtual Study on the Feasibility and Challenges of Decentralized Clinical Trials
di: Yue Ma, et al.
Pubblicazione: (2025)